Cargando…

Multidisciplinary Team Managements and Clinical Outcomes in Patients With Pulmonary Arterial Hypertension During the Perinatal Period

Background: Pulmonary arterial hypertension (PAH) patients with pregnancy have high maternal mortality. This study aimed to provide clinical evidence with multidisciplinary team (MDT) management and to evaluate the clinical outcomes in PAH patients during the perinatal period. Methods: We conducted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shu, Tingting, Feng, Panpan, Liu, Xiaozhu, Wen, Li, Chen, Huaqiao, Chen, Yunwei, Huang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718549/ https://www.ncbi.nlm.nih.gov/pubmed/34977200 http://dx.doi.org/10.3389/fcvm.2021.795765

Ejemplares similares

Management of pregnant patients with pulmonary arterial hypertension
por: Zhang, Xiao, et al.
Publicado: (2022)

Explainable machine learning models for predicting 30-day readmission in pediatric pulmonary hypertension: A multicenter, retrospective study
por: Duan, Minjie, et al.
Publicado: (2022)

Autoimmunity in Pulmonary Arterial Hypertension: Evidence for Local Immunoglobulin Production
por: Shu, Ting, et al.
Publicado: (2021)

An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
por: Santos-Gomes, Joana, et al.
Publicado: (2022)

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022)

Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan
por: Liang, Kae-Woei, et al.
Publicado: (2022)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
por: Tan, Rubin, et al.
Publicado: (2022)

Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension
por: Diekmann, Franziska, et al.
Publicado: (2021)

Validity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China
por: Gong, Su-Gang, et al.
Publicado: (2021)

Anomalous left coronary artery from the pulmonary artery: Outcomes and management of mitral valve
por: Yu, Juemin, et al.
Publicado: (2022)

Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
por: Lai, Jinzhi, et al.
Publicado: (2022)

Differences in disease severity and prognosis of exercise-induced right-to-left shunt between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients
por: Wang, Shang, et al.
Publicado: (2022)

Time to clinical improvement: an appropriate surrogate endpoint for pulmonary arterial hypertension medication trials
por: Wang, An, et al.
Publicado: (2023)

Echocardiographic Prognosis Relevance of Attenuated Right Heart Remodeling in Idiopathic Pulmonary Arterial Hypertension
por: Zhao, Qin-Hua, et al.
Publicado: (2021)

Sex Differences, Estrogen Metabolism and Signaling in the Development of Pulmonary Arterial Hypertension
por: Sun, Yanan, et al.
Publicado: (2021)

Glutaminolysis: A Driver of Vascular and Cardiac Remodeling in Pulmonary Arterial Hypertension
por: Mprah, Richard, et al.
Publicado: (2021)

Echocardiographic, Biochemical, and Electrocardiographic Correlates Associated With Progressive Pulmonary Arterial Hypertension
por: Zaky, Ahmed, et al.
Publicado: (2021)

Schistosome-Associated Pulmonary Arterial Hypertension: A Review Emphasizing Pathogenesis
por: Ferrari, Teresa Cristina Abreu, et al.
Publicado: (2021)

Relaxin Inhibits Ventricular Arrhythmia and Asystole in Rats With Pulmonary Arterial Hypertension
por: Martin, Brian, et al.
Publicado: (2021)

Construction of a diagnostic signature and immune landscape of pulmonary arterial hypertension
por: Duo, Mengjie, et al.
Publicado: (2022)

Pulmonary arterial hypertension associated with congenital heart disease: An omics study
por: Zhao, Maolin, et al.
Publicado: (2023)

Team-Based Care for Improving Hypertension Management: A Pragmatic Randomized Controlled Trial
por: Santschi, Valérie, et al.
Publicado: (2021)

Safety of chronic high-dose calcium channel blockers exposure in children with pulmonary arterial hypertension
por: Wu, Yan, et al.
Publicado: (2022)

Interpretable machine learning for 28-day all-cause in-hospital mortality prediction in critically ill patients with heart failure combined with hypertension: A retrospective cohort study based on medical information mart for intensive care database-IV and eICU databases
por: Peng, Shengxian, et al.
Publicado: (2022)

Bilateral lung transplantation for pediatric pulmonary arterial hypertension: perioperative management and one-year follow-up
por: Jack, Thomas, et al.
Publicado: (2023)

Identification of immune-related hub genes and analysis of infiltrated immune cells of idiopathic pulmonary artery hypertension
por: Chen, Yubin, et al.
Publicado: (2023)

Metabolic Reprogramming in the Heart and Lung in a Murine Model of Pulmonary Arterial Hypertension
por: Izquierdo-Garcia, Jose L., et al.
Publicado: (2018)

Prognostic Value of Gamma-Glutamyltransferase in Male Patients With Idiopathic Pulmonary Arterial Hypertension
por: Lu, Gang-Hua, et al.
Publicado: (2020)

Donepezil Ameliorates Pulmonary Arterial Hypertension by Inhibiting M2-Macrophage Activation
por: Qiu, Haihua, et al.
Publicado: (2021)

Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension
por: Richter, Manuel J., et al.
Publicado: (2021)

Pulmonary Arterial Hypertension and Consecutive Right Heart Failure Lead to Liver Fibrosis
por: Hamberger, Florian, et al.
Publicado: (2022)

Case report: Pulmonary arterial hypertension in ENG-related hereditary hemorrhagic telangiectasia
por: Liu, Dong, et al.
Publicado: (2022)

Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review
por: Lokhorst, Chantal, et al.
Publicado: (2022)

Transcription factors in the pathogenesis of pulmonary arterial hypertension—Current knowledge and therapeutic potential
por: Körbelin, Jakob, et al.
Publicado: (2023)

Case report: Thoughts on two cases of total anomalous pulmonary venous connection complicated with pulmonary artery hypertension
por: Yan, Ling, et al.
Publicado: (2023)

Echocardiographic Evaluation of Initial Ambrisentan Plus Phosphodiesterase Type 5 Inhibitor on Right Ventricular Pulmonary Artery Coupling in Severe Pulmonary Arterial Hypertension Patients
por: Lan, Wei-Fang, et al.
Publicado: (2022)

Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular Assessment
por: Alandejani, Faisal, et al.
Publicado: (2022)

Long-term outcomes of transcatheter Potts shunt in children with suprasystemic pulmonary arterial hypertension
por: Haddad, Raymond N., et al.
Publicado: (2022)

Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension
por: Le Ribeuz, Hélène, et al.
Publicado: (2023)

Case report: Myocardial perfusion gated-SPECT in pulmonary artery hypertension—the Movahed's sign
por: Hamzaraj, Kevin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dtmpn7k3sib7hmo0jqoo2r59hc